President Xi leads major-country diplomacy with Chinese characteristics into a new stage of greater achievements
BEIJING, Dec. 30, 2024 /PRNewswire/ -- "On the new journey, major-country diplomacy with Chinese characteristics will enter a new stage where much more can be accomplished," stated the Central Conference on Work Relating to Foreign Affairs held at...
iQIYI leads genre-specific storytelling with the return of its trend-setting 'Light On Theater,' featuring seven new suspense dramas
Five years on, the pioneering drama brand remains the benchmark for suspense BEIJING, Dec. 26, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, announced this month the return of its acclaimed "Light On Theater,"...
China Matters' Feature: A City That Leads the Trend and Shapes the Future
SHENZHEN, China, Dec. 13, 2024 /PRNewswire/ -- There is no city witnessing greater economic and technological advancement than Shenzhen. After 40 years of significant growth, Shenzhen has transformed from a humble fishing village with a population...
RSNA 2024 Spotlight: Careverse Leads the New Trend in Medical AI
CHICAGO, Dec. 12, 2024 /PRNewswire/ -- From December 1st to 5th, 2024, RSNA 2024—the largest and most future-oriented top medical event in the global radiology community, was held in Chicago. At this conference, Careverse officially made its debut,...
ADGM's Asset Management Sector Leads Exponential Growth in Third Quarter of 2024
ABU DHABI, UAE, Nov. 30, 2024 /PRNewswire/ -- ADGM, the international financial centre ("IFC") of Abu Dhabi, announced another quarter of unprecedented growth, with exceptional achievements for the third quarter ("Q3") of 2024 across key metrics....
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage...